Brent D. G. Page

Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts

Xiaolei Zhang, Peibin Yue, Brent D. G. Page et al. · Proceedings of the National Academy of Sciences · 2012 · 349 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies

Nikolas Herold, Sean G. Rudd, Linda Ljungblad et al. · Nature Medicine · 2017 · 142 citations

Medicine, Hematology, Pharmacology +10

Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia

Anna M. Eiring, Brent D. G. Page, Ira L. Kraft et al. · Leukemia · 2014 · 133 citations · Full text

Medicine, Oncology, Pharmacology +12

NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine

Nicholas C.K. Valerie, Anna Hagenkort, Brent D. G. Page et al. · Cancer Research · 2016 · 127 citations

Medicine, Oncology, Pharmacology +13

Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma

Sina Haftchenary, H. Artee Luchman, Andriana O. Jouk et al. · ACS Medicinal Chemistry Letters · 2013 · 126 citations · Full text

Medicine, Oncology, Pharmacology +17